4-Phenoxybenzoic acid | CAS:2215-77-2
4-Phenoxybenzoic acid
- 名称：4-苯氧基苯甲酸 | 4-Phenoxybenzoic acid
- CAS号：2215-77-2
- 别名：
- 分子式：C13H10O3
- 分子量：214.22
- EINESC号：218-682-5
产品描述
物理化学性质
| 熔点 | 160-164 ºC |
|---|
安全数据
| 危险品标志 | Xi |
|---|---|
| 危险类别码 | R36/37/38 |
| 安全说明书 | S26;S37/39 |
产品合成路线
文章
同行评议文献
Chemokine co-receptor CCR5/CXCR4-dependent modulation of Kv2.1 channel confers acute neuroprotection to HIV-1 glycoprotein gp120 exposure.Andrew J Shepherd et al.PloS one, 8(9), e76698-e76698 (2013-10-03)
Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.Chun-Hui Zheng et al.Cell biology international, 42(10), 1386-1394 (2018-07-05)
Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.Miodrag Dragoj et al.Investigational new drugs, 35(6), 718-732 (2017-07-25)
CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.Thomas A Werner et al.British journal of cancer, 117(12), 1837-1845 (2017-11-08)
Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma.Miodrag Dragoj et al.Cellular oncology (Dordrecht), 40(1), 47-62 (2016-11-09)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
RelatedAPI's
| 名称 | CAS号 | |
|---|---|---|
| PCI-32765 | 936563-96-1 | 查看 |
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称！
- CAS号
- 请正确填写公司名称！
- 请正确填写联系人！
- 请正确填写联系电话！
- 请正确填写联系邮箱！
- 请描述您的问题！